Dr. Schlager has guided the strategic design and implementation of clinical development plans and medical affairs activities for several pharmaceutical companies, including Bristol Myers-Squibb, Astellas, Viatris, GE Healthcare, QED Therapeutics, The Bill and Melinda Gates Medical Research Institute, and Bausch Healthcare. His efforts have led to the global commercialization of products in oncology and hematology, rheumatology, autoimmune disorders, neuromuscular diseases, and rare and orphan drug diseases. Over the past 10 years, he has held leadership roles in the successful filing of 6 NDAs or BLAs in the US and EU. 

Before joining Apimeds, Dr. Schlager was the Senior Clinical Officer at Therapeutic Window™ LLC, a consulting firm that provides clinical and regulatory guidance to the pharmaceutical industry.